Nachrichten zur Poolbeg Pharma PLC Aktie

Poolbeg Pharma gets positive FDA feedback for development pathway of lead cancer therapy asset

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received positive feedback from the US Food and Drug...…

Poolbeg Pharma to present POLB 001 data at European Hematology Association congress

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, will present new data on its lead candidate POLB 001 at...…

Poolbeg Pharma secures Canadian patent for cancer immunotherapy drug POLB 001

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian patent approval covering the use...…

Poolbeg Pharma PLC (POLBF) Q4 2025 Earnings Call Transcript

…

Poolbeg Pharma eyes partnering deals as cancer immunotherapy trial heads for summer data

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, is advancing partnering discussions with multiple...…

Poolbeg Pharma, Arecor Therapeutics, hVIVO, Ilika, Kodal Minerals, Connecting Excellence

…

Poolbeg Pharma advances POLB 001 into UK trial

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) CEO, Jeremy Skillington, talked with Proactive about recent progress alongside Principal Scientist Liam...…

Poolbeg Pharma: trial green-lit, billion-dollar market - and data due this summer

…

Poolbeg Pharma wins UK regulatory clearance for cancer immunotherapy trial

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from...…

Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms

…

Accesso, Light Science Technologies, Poolbeg Pharma, Digitalbox, RC Fornax, Gaming Realms

…

dpa-AFX ProFeed